Net Income Summary of Cochlear Limited

Cochlear Limited's latest annual net income in 2024 was 356.8 Million AUD , up 18.7% from previous year.
Cochlear Limited's latest quarterly net income in 2024 FY was 356.8 Million AUD , up 18.7% from previous quarter.
Cochlear Limited reported an annual net income of 300.6 Million AUD in 2023, up 3.98% from previous year.
Cochlear Limited reported an annual net income of 289.1 Million AUD in 2022, down -11.45% from previous year.
Cochlear Limited reported a quarterly net income of 165.4 Million AUD for 2024 Q4, down 0.0% from previous quarter.
Cochlear Limited reported a quarterly net income of 191.4 Million AUD for 2024 Q2, down 0.0% from previous quarter.

Annual Net Income Chart of Cochlear Limited (2024 - 1996)

Historical Annual Net Income of Cochlear Limited (2024 - 1996)

Year	Net Income	Net Income Growth
2024	356.8 Million AUD	18.7%
2023	300.6 Million AUD	3.98%
2022	289.1 Million AUD	-11.45%
2021	326.5 Million AUD	237.01%
2020	-238.3 Million AUD	-186.12%
2019	276.7 Million AUD	12.57%
2018	245.8 Million AUD	9.92%
2017	223.61 Million AUD	18.36%
2016	188.92 Million AUD	29.54%
2015	145.84 Million AUD	55.63%
2014	93.7 Million AUD	-29.31%
2013	132.56 Million AUD	133.37%
2012	56.8 Million AUD	-68.46%
2011	180.11 Million AUD	16.09%
2010	155.15 Million AUD	18.85%
2009	130.54 Million AUD	13.28%
2008	115.23 Million AUD	15.08%
2007	100.13 Million AUD	25.11%
2006	80.03 Million AUD	6752.05%
2005	1.16 Million AUD	86.28%
2004	627 Thousand AUD	-98.92%
2003	58.21 Million AUD	45.13%
2002	40.11 Million AUD	28.65%
2001	31.17 Million AUD	54.6%
2000	20.16 Million AUD	23.52%
1999	16.32 Million AUD	22.9%
1998	13.28 Million AUD	22.91%
1997	10.8 Million AUD	-0.5%
1996	10.86 Million AUD	0.0%

Year	Net Income	Net Income Growth
2024 FY	356.8 Million AUD	18.7%
2024 Q4	165.4 Million AUD	0.0%
2024 Q2	191.4 Million AUD	0.0%
2023 Q2	141.6 Million AUD	0.0%
2023 FY	300.6 Million AUD	3.98%
2023 Q4	159 Million AUD	0.0%
2022 Q4	119.8 Million AUD	0.0%
2022 Q2	169.3 Million AUD	0.0%
2022 FY	289.1 Million AUD	-11.45%
2021 Q2	236.2 Million AUD	0.0%
2021 FY	326.5 Million AUD	237.01%
2021 Q4	90.3 Million AUD	0.0%
2020 Q2	157.7 Million AUD	0.0%
2020 FY	-238.3 Million AUD	-186.12%
2020 Q4	-396 Million AUD	0.0%
2019 Q2	128.6 Million AUD	0.0%
2019 Q4	148.1 Million AUD	0.0%
2019 FY	276.7 Million AUD	12.57%
2018 Q4	135 Million AUD	0.0%
2018 FY	245.8 Million AUD	9.92%
2018 Q2	110.8 Million AUD	0.0%
2017 Q4	112.2 Million AUD	0.0%
2017 FY	223.61 Million AUD	18.36%
2017 Q2	111.4 Million AUD	0.0%
2016 FY	188.92 Million AUD	29.54%
2016 Q4	94.88 Million AUD	0.0%
2016 Q2	94.03 Million AUD	0.0%
2015 Q4	74.46 Million AUD	0.0%
2015 Q2	71.37 Million AUD	0.0%
2015 FY	145.84 Million AUD	55.63%
2014 Q2	21.04 Million AUD	0.0%
2014 FY	93.7 Million AUD	-29.31%
2014 Q4	72.66 Million AUD	0.0%
2013 Q4	54.89 Million AUD	65.65%
2013 Q3	33.14 Million AUD	0.0%
2013 Q2	33.14 Million AUD	133.37%
2013 Q1	14.2 Million AUD	0.0%
2013 FY	132.56 Million AUD	133.37%
2012 Q4	- AUD	-100.0%
2012 Q2	14.2 Million AUD	-68.46%
2012 Q1	45.02 Million AUD	0.0%
2012 FY	56.8 Million AUD	-68.46%
2012 Q3	14.2 Million AUD	0.0%
2011 Q1	38.78 Million AUD	0.0%
2011 Q2	45.02 Million AUD	16.09%
2011 Q3	45.02 Million AUD	0.0%
2011 Q4	- AUD	-100.0%
2011 FY	180.11 Million AUD	16.09%
2010 FY	155.15 Million AUD	18.85%
2010 Q4	- AUD	-100.0%
2010 Q3	38.78 Million AUD	0.0%
2010 Q2	38.78 Million AUD	18.85%
2010 Q1	32.63 Million AUD	0.0%
2009 Q2	32.63 Million AUD	13.28%
2009 FY	130.54 Million AUD	13.28%
2009 Q3	32.63 Million AUD	0.0%
2009 Q1	28.8 Million AUD	0.0%
2009 Q4	- AUD	-100.0%
2008 Q1	25.03 Million AUD	0.0%
2008 Q2	28.8 Million AUD	15.08%
2008 Q4	- AUD	-100.0%
2008 FY	115.23 Million AUD	15.08%
2008 Q3	28.8 Million AUD	0.0%
2007 FY	100.13 Million AUD	25.11%
2007 Q3	25.03 Million AUD	0.0%
2007 Q4	- AUD	-100.0%
2007 Q2	25.03 Million AUD	25.11%
2007 Q1	20 Million AUD	0.0%
2006 FY	80.03 Million AUD	6752.05%
2006 Q4	- AUD	-100.0%
2006 Q3	20 Million AUD	0.0%
2006 Q2	20 Million AUD	6752.05%
2006 Q1	292 Thousand AUD	0.0%
2005 Q1	156.75 Thousand AUD	0.0%
2005 Q2	292 Thousand AUD	86.28%
2005 Q3	292 Thousand AUD	0.0%
2005 Q4	- AUD	-100.0%
2005 FY	1.16 Million AUD	86.28%
2004 Q1	14.55 Million AUD	0.0%
2004 FY	627 Thousand AUD	-98.92%
2004 Q2	156.75 Thousand AUD	-98.92%
2004 Q3	156.75 Thousand AUD	0.0%
2004 Q4	- AUD	-100.0%
2003 FY	58.21 Million AUD	45.13%
2003 Q2	14.55 Million AUD	45.13%
2003 Q1	10.02 Million AUD	0.0%
2003 Q3	14.55 Million AUD	0.0%
2003 Q4	- AUD	-100.0%
2002 FY	40.11 Million AUD	28.65%
2002 Q2	10.02 Million AUD	28.65%
2002 Q3	10.02 Million AUD	0.0%
2002 Q4	- AUD	-100.0%
2002 Q1	7.79 Million AUD	0.0%
2001 Q1	5.04 Million AUD	0.0%
2001 Q3	7.79 Million AUD	0.0%
2001 Q4	- AUD	-100.0%
2001 FY	31.17 Million AUD	54.6%
2001 Q2	7.79 Million AUD	54.6%
2000 Q4	- AUD	-100.0%
2000 FY	20.16 Million AUD	23.52%
2000 Q2	5.04 Million AUD	23.52%
2000 Q1	4.08 Million AUD	0.0%
2000 Q3	5.04 Million AUD	0.0%
1999 Q3	4.08 Million AUD	0.0%
1999 Q2	4.08 Million AUD	22.9%
1999 Q1	3.32 Million AUD	0.0%
1999 FY	16.32 Million AUD	22.9%
1999 Q4	- AUD	-100.0%
1998 Q4	- AUD	-100.0%
1998 FY	13.28 Million AUD	22.91%
1998 Q1	2.7 Million AUD	0.0%
1998 Q3	3.32 Million AUD	0.0%
1998 Q2	3.32 Million AUD	22.91%
1997 Q4	- AUD	-100.0%
1997 Q1	2.71 Million AUD	0.0%
1997 Q2	2.7 Million AUD	-0.5%
1997 Q3	2.7 Million AUD	0.0%
1997 FY	10.8 Million AUD	-0.5%
1996 Q3	2.71 Million AUD	0.0%
1996 Q2	2.71 Million AUD	0.0%
1996 Q4	2.71 Million AUD	0.0%
1996 FY	10.86 Million AUD	0.0%

Peer Net Income Comparison of Cochlear Limited

Name	Net Income	Net Income Difference
4DMedical Limited	-35.97 Million AUD	1091.699%
Adherium Limited	-10.22 Million AUD	3589.769%
Aroa Biosurgery Limited	-9.74 Million AUD	3760.138%
Atomo Diagnostics Limited	-6.84 Million AUD	5310.43%
Anteris Technologies Ltd	-67.33 Million AUD	629.901%
Control Bionics Limited	-5.91 Million AUD	6133.367%
CardieX Limited	-6.76 Million AUD	5373.921%
Compumedics Limited	-338 Thousand AUD	105662.13%
CleanSpace Holdings Limited	-3.12 Million AUD	11509.783%
Cyclopharm Limited	-4.7 Million AUD	7690.188%
EMVision Medical Devices Ltd	-2.72 Million AUD	13171.464%
Nova Eye Medical Limited	-8.79 Million AUD	4159.158%
HeraMED Limited	-6.78 Million AUD	5359.691%
Imricor Medical Systems, Inc.	-22.62 Million AUD	1676.954%
ImpediMed Limited	-19.79 Million AUD	1902.931%
InhaleRx Limited	-1.44 Million AUD	24821.622%
LBT Innovations Limited	-3.74 Million AUD	9640.107%
Micro-X Limited	-9.76 Million AUD	3753.866%
Neurotech International Limited	-5.06 Million AUD	7138.515%
OncoSil Medical Limited	-11.91 Million AUD	3094.889%
PolyNovo Limited	5.26 Million AUD	-6681.981%
Respiri Limited	-7.12 Million AUD	5104.736%
SomnoMed Limited	-12.24 Million AUD	3014.622%
Universal Biosensors, Inc.	-6.74 Million AUD	5392.54%
Uscom Limited	-2.07 Million AUD	17297.261%
Visioneering Technologies, Inc.	-5.06 Million AUD	7146.778%

Global Stocks Search

Cochlear Limited (COH.AX)

Net Income Summary of Cochlear Limited

Annual Net Income Chart of Cochlear Limited (2024 - 1996)

Historical Annual Net Income of Cochlear Limited (2024 - 1996)

Peer Net Income Comparison of Cochlear Limited